Immortal human cells maintain their telomeres by two independent mechanisms
, a prevalent one dependent on de novo synthesis of telomeric DNA by telome
rase, and a rarer one based on telomere recombination [alternative lengthen
ing of telomeres (ALT)]. Studies with yeast have indicated that expression
of telomerase inhibits telomere recombination. In the present study, we hav
e investigated whether expression of telomerase in cells that use ALT would
similarly reveal dominance of telomere elongation by telomerase over telom
ere recombination. Telomerase-negative WI38 VA13/2RA ALT cells were reconst
ituted for telomerase activity through ectopic expression of the enzyme sub
units, hTERT and hTR, and the presence and function of telomerase and ALT w
ere monitored during long term cell growth by enzymatic assays, detection o
f the ALT-associated PML bodies (APBs) and analysis of telomere dynamics. O
ur results indicate that telomerase activity and APBs persisted in the cell
s over at least 90 population doublings. The activity of both pathways on t
elomeres was determined by analysis of telomere length versus time by gel e
lectrophoresis and in situ hybridization. ALT cells are characterized by ve
ry heterogeneous telomeres with a much longer average size than the telomer
es of telomerase-positive cells. Telomere dynamics in our cells were compat
ible with both ALT and telomerase being biologically active since the long
telomeres typical of ALT were maintained, while short telomeres, thought to
be the preferential substrate of telomerase, were elongated. These finding
s, indicating that human cells may be capable of concomitantly utilizing bo
th mechanisms of telomere maintenance without effects on their growth and v
iability, have implications for cancer therapy.